| Financial Year |
March 31 2023 |
| Monetary Funds |
217,541,064.61 |
| Held-for-trading Financial Assets |
1,898,367.33 |
| Notes Receivable |
23,544,823.69 |
| Accounts Receivable |
713,862,280.86 |
| Advances to Suppliers |
15,815,127.83 |
| Other Receivables |
21,802,831.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
450,473,406.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
416,904.24 |
| Other Current Assets |
18,913,428.81 |
| Total Current Assets |
1,484,013,261.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
26,207,142.16 |
| Long-term Equity Investment |
6,578,521.49 |
| Investment Properties |
-- |
| Fixed Assetes |
667,701,818.97 |
| Under-construction Projects |
2,406,614.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
194,772,455.10 |
| R&D expenses |
122,209,303.22 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,011,318.62 |
| Deferred Income Tax Assets |
21,408,332.00 |
| Other Non-Current Assets |
789,571.91 |
| Sub-Total of Non-Current Assets |
1,061,932,614.22 |
| Total Assets |
2,545,945,875.54 |
| Short-Term Loans |
433,003,055.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
178,571,738.76 |
| Accounts Payable |
654,894,836.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
49,716,764.24 |
| Taxes Payable |
5,548,311.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
30,698,581.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
116,865,136.10 |
| Other Current Liabilities |
12,278,059.99 |
| Sub-Total of Current Liabilities |
1,518,853,169.06 |
| Long-term Loans |
97,688,228.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
65,694,892.26 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
178,112,052.80 |
| Total Liabilities |
1,696,965,221.86 |
| Paid-In Capital(Or Share Stock) |
553,275,448.00 |
| Capital Surplus |
503,369,470.65 |
| Surplus Reserve |
34,371,811.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-257,728,499.06 |
| Minority Stockholder's Interest |
13,993,983.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
834,986,670.48 |
| Owner's Equity（Stockholder's Equity） |
848,980,653.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,545,945,875.54 |
